COMMUNIQUÉS West-GlobeNewswire

Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure
11/02/2026
Ji'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that [...]
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
11/02/2026
Launch of Inspire V system complete with strong revenue and profitability performance in the fourth quarter and FDA approval for 3.0T MRI compatibility Fourth quarter revenue growth of 12% and full year revenue growth [...]
Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results
11/02/2026
SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and [...]
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
11/02/2026
CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth [...]
Tectonic Therapeutic to Host Virtual KOL Event and Discussion of TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia, on February 24, 2026
11/02/2026
WATERTOWN, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc . (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and [...]
Ascendis Pharma Reports Fourth Quarter and Full-Year 2025 Financial Results
11/02/2026
Q4 2025 product revenue of €240 million and FY 2025 product revenue of €684 million Q4 2025 operating profit of €10 million and cash flow from operating activities of €73 million TransCon ® CNP under FDA Priority Review [...]
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
11/02/2026
REDWOOD CITY, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY) ("Biotricity" or the "Company”), an innovative Technology-as-a-Service (TaaS) company committed to transforming chronic condition [...]
MemoTril Product Information Updated as Consumer Interest in Brain Health and Cognitive Support Supplement Options Grows in 2026
11/02/2026
Examining MemoTril ingredient disclosures, category context for brain health and memory support supplements, and the transparency factors consumers consider when comparing cognitive support options in 2026 New York, NY [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11/02/2026
Bagsværd, Denmark, 11 February 2026 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Sanofi: Information concerning the total number of voting rights and shares – January 2026
11/02/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Sanofi: Informations relatives au nombre de droits de vote et d'actions – JANVIER 2026
11/02/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
EssilorLuxottica: EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors
11/02/2026
EssilorLuxottica Board of Directors Proposes Renewal of Eight Directors Paris, France (11 February 2026 – 6:00pm) – During its meeting today, EssilorLuxottica Board of Directors decided to propose to the Shareholders’ [...]
EssilorLuxottica: Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices
11/02/2026
Le Conseil d’administration d’EssilorLuxottica propose la nomination de huit administrateurs et administratrices Paris, France (11 février 2026 – 18h00) – Réuni aujourd’hui, le Conseil d’administration d’ [...]
Cosmos Health Expands Digital Assets Program with $500,000 Bitcoin Purchase, Bringing Total Cryptocurrency Investments to $2.5 Million; Evaluates Inclusion of Other Select Cryptocurrencies
11/02/2026
CHICAGO, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the expansion of its digital [...]
EssilorLuxottica: Q4/FY 2025 Results - Revenue growing 18.4% in Q4 and 11.2% in the FY. Adj. operating margin at 16.0% in the FY
11/02/2026
Revenue 1 growing 18.4% in Q4 and 11.2% in the FY Adj. operating margin 1 ,2 at 16.0% in the FY Group’s revenue at Euro 28,491 million in the FY, +11.2% at constant exchange rates 1 , with Q4 at +18.4% North America, [...]
EssilorLuxottica: Résultats T4 et annuels 2025 - Hausse de +18,4 % du chiffre d'affaires au T4 et de +11,2 % sur l'exercice. Marge opérationnelle ajustée à 16,0 % sur l'exercice
11/02/2026
Hausse de +18,4 % du chiffre d'affaires 1 au T4 et de +11,2 % sur l'exercice Marge opérationnelle ajustée 1,2 à 16,0 % sur l'exercice Chiffre d’affaires annuel du Groupe à 28 491 millions d’euros, +11,2 % à taux de [...]
VALNEVA Declaration of shares and voting rights: January 31, 2026
11/02/2026
VALNEVA Declaration of shares and voting rights January 31, 2026 __________________________________________________________________________________________ Company name: VALNEVA Registered office: Îlot Saint-Joseph [...]
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026
11/02/2026
VALNEVA Déclaration d’actions et de droits de vote 31 janvier 2026 __________________________________________________________________________________________ Dénomination sociale : VALNEVA Adresse du siège social : Îlot [...]
Booking Health Releases 2026 Global Overview of Leading Cancer Hospitals Amid Growing Demand for International Oncology Care
11/02/2026
Langenfeld, Germany, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Booking Health , an international medical travel coordination service, today released a comprehensive 2026 overview of leading cancer hospitals worldwide, [...]

Pages